Drugs such as semaglutide (brand names: Ozempic, Wegovy) and liraglutide (Saxenda) are part of a class of medications known as GLP-1 receptor agonists (GLP-1 RAs)
Improved cardiovascular fitness and reduced inflammation associated with weight loss may also enhance physical stamina and vascular function, which are important for sexual performance
As the dosage is adjusted to a maintenance level, patients can anticipate more noticeable weight loss
For an orientation to the broader Injectable Diabetes Medications, see this overview for class-by-class context
It is important to recognise that patients prescribed GLP-1 agonists often have underlying conditionssuch as type 2 diabetes, obesity, hypertension, and dyslipidaemiathat independently increase cardiovascular and thrombotic risk
Hantschke M, Mentzel T, Kutzner H